Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
VREX 
Varex Imaging Corp (VREX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/27/2025: VREX (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -26.72% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/27/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 498.07M USD | Price to earnings Ratio - | 1Y Target Price 21.2 |
Price to earnings Ratio - | 1Y Target Price 21.2 | ||
Volume (30-day avg) 371956 | Beta 0.57 | 52 Weeks Range 10.19 - 18.30 | Updated Date 03/27/2025 |
52 Weeks Range 10.19 - 18.30 | Updated Date 03/27/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.17 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -5.79% | Operating Margin (TTM) 5.61% |
Management Effectiveness
Return on Assets (TTM) 1.9% | Return on Equity (TTM) -8.25% |
Valuation
Trailing PE - | Forward PE 57.47 | Enterprise Value 877570480 | Price to Sales(TTM) 0.61 |
Enterprise Value 877570480 | Price to Sales(TTM) 0.61 | ||
Enterprise Value to Revenue 1.07 | Enterprise Value to EBITDA 13.52 | Shares Outstanding 41231000 | Shares Floating 40658632 |
Shares Outstanding 41231000 | Shares Floating 40658632 | ||
Percent Insiders 1.7 | Percent Institutions 97.32 |
Analyst Ratings
Rating 4.4 | Target Price 22.2 | Buy 1 | Strong Buy 3 |
Buy 1 | Strong Buy 3 | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Varex Imaging Corp
Company Overview
History and Background
Varex Imaging Corp. was founded in 1936 as the medical division of a larger company, later becoming an independent company specializing in medical imaging components. It evolved through acquisitions and strategic shifts, focusing on X-ray imaging technology.
Core Business Areas
- Medical: Provides X-ray tubes, digital detectors, and other imaging components for medical diagnostic applications such as radiography, fluoroscopy, and mammography.
- Industrial: Offers X-ray imaging solutions for industrial inspection, non-destructive testing, and security applications. Products include X-ray tubes, detectors, and software for industrial computed tomography and radiography.
- Security: Provides X-ray imaging solutions for cargo screening, baggage scanning, and personnel screening at airports, borders, and other security checkpoints.
Leadership and Structure
The leadership team includes key executives in roles such as CEO, CFO, and heads of various business units. The organizational structure is typically hierarchical, with functional departments supporting the business segments.
Top Products and Market Share
Key Offerings
- X-Ray Tubes: Varex is a leading manufacturer of X-ray tubes for medical and industrial applications. Market share is estimated around 35-40%. Competitors include Dunlee (Philips) and Canon Electron Tubes & Devices Co., Ltd. Revenue derived is part of Medical and Industrial Segments.
- Digital Detectors: Offers flat panel digital detectors for radiography, fluoroscopy, and other imaging modalities. Market share is estimated around 20-25%. Competitors include Canon, Trixell (Thales), and Fujifilm. Revenue derived is part of Medical and Industrial Segments.
- Software and Workstations: Provides imaging software and workstations for image acquisition, processing, and analysis. Market share is estimated around 10-15%. Competitors include Sectra and Visage Imaging. Revenue derived is part of Medical Segment.
Market Dynamics
Industry Overview
The medical and industrial imaging market is driven by aging populations, increasing healthcare spending, and technological advancements. Demand for advanced imaging modalities and non-destructive testing is growing.
Positioning
Varex Imaging Corp is positioned as a key supplier of components and solutions for X-ray imaging. Its competitive advantages include its broad product portfolio, established customer relationships, and technical expertise.
Total Addressable Market (TAM)
The total addressable market for medical and industrial X-ray imaging is estimated to be in the billions of dollars. Varex is positioned to address a significant portion of this TAM through its diverse product offerings.
Upturn SWOT Analysis
Strengths
- Strong market position in X-ray components
- Diverse product portfolio
- Established customer relationships
- Technical expertise
- Global presence
Weaknesses
- Dependence on X-ray technology
- Exposure to healthcare spending trends
- Competitive pricing pressures
- Supply chain vulnerabilities
- Fluctuations in Raw Materials Cost
Opportunities
- Growth in emerging markets
- Adoption of advanced imaging modalities
- Expansion into new applications
- Strategic acquisitions
- Increased demand from security applications
Threats
- Technological obsolescence
- Increased competition
- Regulatory changes
- Economic downturns
- Geopolitical instability
Competitors and Market Share
Key Competitors
- Canon (CAJ)
- Thales (HO)
- Fujifilm (FUJIY)
Competitive Landscape
Varex has strengths in component manufacturing, while competitors may have broader imaging system solutions. Varex's advantage lies in its specialized expertise and global reach in component supply.
Major Acquisitions
Direct Conversion AB
- Year: 2017
- Acquisition Price (USD millions): 80
- Strategic Rationale: Enhanced capabilities in photon counting detectors.
Growth Trajectory and Initiatives
Historical Growth: Historical growth can be assessed using revenue and earnings data from past years, showing the rate of expansion or contraction.
Future Projections: Future projections are based on analyst estimates, which consider market trends, company strategies, and macroeconomic factors.
Recent Initiatives: Recent strategic initiatives typically include new product launches, acquisitions, partnerships, and market expansions.
Summary
Varex Imaging Corp. holds a solid position in the X-ray imaging component market, supported by a diverse product line and established customer base. While strengths include its technical expertise and global reach, it faces competition and must adapt to technological changes. Growth opportunities lie in emerging markets and new applications, but potential threats include regulatory changes and economic downturns. Varex needs to continue to innovate and adapt to stay competitive.
Similar Companies
- CAJ
- HO
- FUJIY
- GE
- SIEMENS (SIE.DE)
Sources and Disclaimers
Data Sources:
- Company website
- SEC filings
- Analyst reports
- Industry publications
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Market share estimates are approximate.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Varex Imaging Corp
Exchange NASDAQ | Headquaters Salt Lake City, UT, United States | ||
IPO Launch date 2017-01-20 | President, CEO & Director Mr. Sunny S. Sanyal | ||
Sector Healthcare | Industry Medical Devices | Full time employees 2300 | Website https://www.vareximaging.com |
Full time employees 2300 | Website https://www.vareximaging.com | ||
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.